CMC

41.68

-11.56%↓

FUL

54.19

-6.73%↓

USAU

9.01

-4.25%↓

CMC

41.68

-11.56%↓

FUL

54.19

-6.73%↓

USAU

9.01

-4.25%↓

CMC

41.68

-11.56%↓

FUL

54.19

-6.73%↓

USAU

9.01

-4.25%↓

CMC

41.68

-11.56%↓

FUL

54.19

-6.73%↓

USAU

9.01

-4.25%↓

CMC

41.68

-11.56%↓

FUL

54.19

-6.73%↓

USAU

9.01

-4.25%↓

Search

Ashland Global Holdings Inc

Closed

SectorBasic materials

53.01 -8.48

Overview

Share price change

24h

Current

Min

52.92

Max

57.66

Key metrics

By Trading Economics

Income

-181M

-165M

Sales

-117M

405M

EPS

0.28

Dividend yield

2.73

Profit margin

-40.741

Employees

3,200

EBITDA

-223M

-140M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+34.54% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

2.73%

2.80%

Next Earnings

29 Apr 2025

Next Dividend date

13 Jun 2025

Next Ex Dividend date

30 May 2025

Market Stats

By TradingEconomics

Market Cap

2.8B

Previous open

61.49

Previous close

53.01

News Sentiment

By Acuity

50%

50%

89 / 170 Basic materials

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Ashland Global Holdings Inc Chart

Past performance is not a reliable indicator of future results.

Related News

17 Mar 2025, 11:00 UTC

Acquisitions, Mergers, Takeovers

Ashland Completes Sale of Avoca Business to Mane

28 Jan 2025, 22:05 UTC

Earnings

Ashland 1Q Adj EPS 28c >ASH

28 Jan 2025, 22:04 UTC

Earnings

Ashland Backs FY25 Sales $1.9B-$2.05B >ASH

28 Jan 2025, 22:04 UTC

Earnings

Ashland 1Q Sales $405M >ASH

28 Jan 2025, 22:04 UTC

Earnings

Ashland 1Q Cont Ops Loss/Shr $3.51 >ASH

28 Jan 2025, 22:03 UTC

Earnings

Ashland 1Q Loss/Shr $3.50 >ASH

6 Nov 2024, 22:07 UTC

Earnings

Ashland 4Q EPS 39c >ASH

6 Nov 2024, 22:07 UTC

Earnings

Ashland 4Q Sales $522M >ASH

6 Nov 2024, 22:07 UTC

Earnings

Ashland Sees FY25 Sales $1.90B-$2.05B >ASH

3 Sept 2024, 11:00 UTC

Acquisitions, Mergers, Takeovers

Ashland Completes Sale of Nutraceuticals Business to Affil of Turnspire Capital Partners >ASH

6 Aug 2024, 21:04 UTC

Earnings

Ashland Sees FY Sales $2.1B >ASH

6 Aug 2024, 21:03 UTC

Earnings

Ashland Sees 4Q Sales $530M-$540M >ASH

6 Aug 2024, 21:03 UTC

Earnings

Ashland 3Q Adj EPS $1.49 >ASH

6 Aug 2024, 21:02 UTC

Earnings

Ashland 3Q Sales $544M >ASH

6 Aug 2024, 21:02 UTC

Earnings

Ashland 3Q Cont Ops EPS 60c >ASH

6 Aug 2024, 21:02 UTC

Earnings

Ashland 3Q EPS 12c >ASH

6 Aug 2024, 21:02 UTC

Earnings

Ashland Issues Outlook for 4Q and Full-Yr Fiscal 2024

7 May 2024, 11:01 UTC

Acquisitions, Mergers, Takeovers

Ashland: Transaction Is Expected to Close in 3Q >ASH

7 May 2024, 10:59 UTC

Acquisitions, Mergers, Takeovers

Ashland Signs Definitive Agreement to Sell Nutraceuticals Business to Turnspire Capital Partners >ASH

Peer Comparison

Price change

Ashland Global Holdings Inc Forecast

Price Target

By TipRanks

34.54% upside

12 Months Forecast

Average 77.86 USD  34.54%

High 93 USD

Low 68 USD

Based on 8 Wall Street analysts offering 12 month price targets forAshland Global Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

5

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

56.5656 / 59.72Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Weak Bearish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

89 / 170 Basic materials

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Ashland Global Holdings Inc

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.